|
Volumn 24, Issue 7, 2018, Pages 927-930
|
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROTEIN P21;
PROTEIN P53;
RETINOBLASTOMA PROTEIN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
RIBONUCLEOPROTEIN;
ARTICLE;
CONTROLLED STUDY;
CRISPR-CAS9 SYSTEM;
DNA DAMAGE RESPONSE;
G1 PHASE CELL CYCLE CHECKPOINT;
GENE EDITING;
HOMOLOGOUS RECOMBINATION;
HUMAN;
HUMAN CELL;
IMMORTALIZED CELL LINE;
PIGMENT CELL;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
RETINAL PIGMENT EPITHELIUM;
CELL CYCLE;
CRISPR CAS SYSTEM;
DNA DAMAGE;
GENETICS;
HEK293 CELL LINE;
METABOLISM;
TUMOR CELL LINE;
CELL CYCLE;
CELL LINE, TUMOR;
CRISPR-ASSOCIATED PROTEIN 9;
CRISPR-CAS SYSTEMS;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
DNA DAMAGE;
GENE EDITING;
HEK293 CELLS;
HUMANS;
RIBONUCLEOPROTEINS;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 85048349385
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/s41591-018-0049-z Document Type: Article |
Times cited : (838)
|
References (18)
|